Kandall S R, Gaines J, Habel L, Davidson G, Jessop D
Division of Neonatology, Beth Israel Medical Center, New York, NY 10003.
J Pediatr. 1993 Jul;123(1):120-6. doi: 10.1016/s0022-3476(05)81554-9.
To assess the possible relationship between maternal drug use during pregnancy and subsequent sudden infant death syndrome (SIDS), we identified 1760 cases of SIDS from a population of more than 1.2 million infants (1.45/1000) born in New York City between 1979 and 1989. The SIDS rate in drug-exposed infants was 5.83 per 1000 infants, compared with 1.39 per 1000 infants who were not drug exposed. With control for known associated high-risk variables, the risk ratio for SIDS in each individual drug group (methadone, 3.6; heroin, 2.3; methadone and heroin, 3.2; cocaine, 1.6; cocaine and methadone or heroin, 1.1) was higher than in the non-drug-exposed group. Higher rates of SIDS were found in infants exposed to opiates alone than in cocaine-exposed infants, but increasing rates of SIDS in cocaine-exposed infants toward the end of the decade suggested that "crack" cocaine may be linked to these increasing rates. Declines in the overall rate of SIDS during the decade were observed for both the drug-exposed (11.28 to 4.09 per 1000) and the nonexposed groups (1.70 to 1.05 per 1000). Differences in rates of SIDS between major racial-ethnic groups in nonexposed infants were not apparent if the mothers used drugs during pregnancy. Seasonal variation and distribution of ages at time of SIDS death did not differ between the drug-exposed group and the nonexposed group, suggesting that drug-associated SIDS may provide clues as to the cause or causes of SIDS.
为评估孕期母亲使用药物与随后发生的婴儿猝死综合征(SIDS)之间可能存在的关系,我们从1979年至1989年在纽约市出生的超过120万婴儿(发病率为1.45/1000)群体中确定了1760例SIDS病例。暴露于药物的婴儿中SIDS发病率为每1000名婴儿5.83例,而未暴露于药物的婴儿中该发病率为每1000名婴儿1.39例。在对已知相关高危变量进行控制后,每个单独药物组(美沙酮,3.6;海洛因,2.3;美沙酮和海洛因,3.2;可卡因,1.6;可卡因与美沙酮或海洛因,1.1)中SIDS的风险比均高于未暴露于药物的组。单独暴露于阿片类药物的婴儿中SIDS发生率高于暴露于可卡因的婴儿,但在该十年末期,暴露于可卡因的婴儿中SIDS发生率不断上升,这表明“快克”可卡因可能与这些上升的发生率有关。在该十年期间,暴露于药物的组(从每1000名婴儿11.28例降至4.09例)和未暴露于药物的组(从每1000名婴儿1.70例降至1.05例)的SIDS总体发生率均有所下降。如果母亲在孕期使用药物,未暴露于药物的婴儿中主要种族-族裔群体之间的SIDS发生率差异不明显。暴露于药物的组和未暴露于药物的组之间,SIDS死亡时的季节变化和年龄分布没有差异,这表明与药物相关的SIDS可能为SIDS病因提供线索。